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Abstract 
INTRODUCTION: The Health of the Nation Outcome Scales (HoNOS) for adults, and equivalent measures 
for children and adolescents and older people, are widely used in clinical practice and research contexts 
to measure mental health and functional outcomes. Additional HoNOS measures have been developed 
for special populations and applications. Stakeholders require synthesised information about the 
measurement properties of these measures to assess whether they are fit for use with intended service 
settings and populations and to establish performance benchmarks. This planned systematic review will 
critically appraise evidence on the measurement properties of the HoNOS family of measures. METHODS 
AND ANALYSIS: Journal articles meeting inclusion criteria will be identified via a search of seven 
electronic databases: MEDLINE via EBSCOhost, PsycINFO via APA PsycNET, Embase via Elsevier, 
Cumulative Index to Nursing and Allied Health Literature via EBSCOhost, Web of Science via Thomson 
Reuters, Google Scholar and the Cochrane Library. Variants of 'Health of the Nation Outcome Scales' or 
'HoNOS' will be searched as text words. No restrictions will be placed on setting or language of 
publication. Reference lists of relevant studies and reviews will be scanned for additional eligible studies. 
Appraisal of reliability, validity, responsiveness and interpretability will be guided by the COnsensus-based 
Standards for the selection of health Measurement INstruments checklist. Feasibility/utility will be 
appraised using definitions and criteria derived from previous reviews. For reliability studies, we will also 
apply the Guidelines for Reporting Reliability and Agreement Studies to assess quality of reporting. 
Results will be synthesised narratively, separately for each measure, and by subgroup (eg, treatment 
setting, rater profession/experience or training) where possible. Meta-analyses will be undertaken where 
data are adequate. ETHICS AND DISSEMINATION: Ethics approval is not required as no primary data will 
be collected. Outcomes will be disseminated to stakeholders via reports, journal articles and 
presentations at meetings and conferences. 
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Protocol
AbstrACt
Introduction The Health of the Nation Outcome Scales 
(HoNOS) for adults, and equivalent measures for children 
and adolescents and older people, are widely used in clinical 
practice and research contexts to measure mental health 
and functional outcomes. Additional HoNOS measures have 
been developed for special populations and applications. 
Stakeholders require synthesised information about the 
measurement properties of these measures to assess 
whether they are fit for use with intended service settings and 
populations and to establish performance benchmarks. This 
planned systematic review will critically appraise evidence on 
the measurement properties of the HoNOS family of measures.
Methods and analysis Journal articles meeting inclusion 
criteria will be identified via a search of seven electronic 
databases: MEDLINE via EBSCOhost, PsycINFO via APA 
PsycNET, Embase via Elsevier, Cumulative Index to Nursing 
and Allied Health Literature via EBSCOhost, Web of Science 
via Thomson Reuters, Google Scholar and the Cochrane 
Library. Variants of ‘Health of the Nation Outcome Scales’ or 
‘HoNOS’ will be searched as text words. No restrictions will be 
placed on setting or language of publication. Reference lists 
of relevant studies and reviews will be scanned for additional 
eligible studies. Appraisal of reliability, validity, responsiveness 
and interpretability will be guided by the COnsensus-
based Standards for the selection of health Measurement 
INstruments checklist. Feasibility/utility will be appraised 
using definitions and criteria derived from previous reviews. 
For reliability studies, we will also apply the Guidelines for 
Reporting Reliability and Agreement Studies to assess quality 
of reporting. Results will be synthesised narratively, separately 
for each measure, and by subgroup (eg, treatment setting, 
rater profession/experience or training) where possible. Meta-
analyses will be undertaken where data are adequate.
Ethics and dissemination Ethics approval is not required 
as no primary data will be collected. Outcomes will be 
disseminated to stakeholders via reports, journal articles 
and presentations at meetings and conferences.
PrOsPErO registration number CRD42017057871.
IntrOduCtIOn  
In 1992, UK’s Health of the Nation strategy 
set a target to ‘improve significantly the 
health and social functioning of mentally ill 
people’.1 The Health of the Nation Outcome 
Scales (HoNOS)2 was developed under the 
auspices of the Royal College of Psychiatrists 
as a means of quantifying progress against 
this target. The HoNOS was developed as a 
clinician-rated measure for use with work-
ing-age adults in contact with mental health 
services. It comprises 12 scales assessing 
behaviour, impairment, symptoms and social 
functioning. Each scale is scored on a five-
point scale representing maximum severity 
over the rating period, typically the previous 
2 weeks (0=no problem; 1=minor problem 
requiring no action; 2=mild problem but defi-
nitely present; 3=moderately severe problem; 
4=severe to very severe problem). Scoring is 
guided by a glossary that provides specific 
anchor points for each scale. Subscale and 
total scores can be derived. Scores are based 
on clinical judgement, and can be used to 
guide patient treatment, resulting in the 
strengths and limitations of this study
 ► This systematic review will apply structured check-
lists that standardise the appraisal of available 
evidence.
 ► The review potentially extends previous systematic 
reviews on the topic by including meta-analyses of 
relevant measurement property metrics, if data are 
adequate.
 ► The review focuses on clinician-rated versions of the 
Health of the Nation Outcome Scales (HoNOS) family 
of measures; it does not include self- or proxy-com-
pleted versions.
 ► To reduce potential language bias, the review will 
include all relevant studies regardless of language 
of publication and studies using translated versions 
of the HoNOS family of measures.
 ► The search strategy does not include dissertations 
and reports; this may mean that a small amount of 
relevant information is missed.
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provision of targeted care and support for clinical deci-
sion-making.3 In addition to its application in clinical 
practice, the HoNOS has also been used by researchers 
and policy-makers to monitor mental health service 
quality and effectiveness.4 
In the decade following the development of the 
HoNOS, it was acknowledged that additional variants 
were required for use with specific populations.5 6 This 
resulted in the development of the HoNOS for Children 
and Adolescents (HoNOSCA),5 and the HoNOS for older 
adults (HoNOS 65+).6 Since then, the HoNOS family of 
measures has been extended to include the following: 
the HoNOS for adults confined to a secure facility 
(HoNOS-secure)7; the HoNOS for Acquired Brain Injury 
(HoNOS-ABI)8 and the HoNOS for People with Learning 
Disabilities (HoNOS-LD).9 Other variants of the HoNOS 
have been developed for administrative and research 
purposes, including the HoNOS for Payment by Results 
(HoNOS PbR)10 for casemix classification. All HoNOS 
measures apply the same scale scoring approach, but the 
number and content of the scales, and the subscale and 
total score structures, are tailored to the population or 
purpose (see online supplementary appendix 1 for an 
overview of the HoNOS measures).
HoNOS measures are widely used in clinical practice 
and research contexts. The HoNOS, HoNOSCA and 
HoNOS 65+ are now the most widely used routine outcome 
measures in mental health services in England.4 11 In 
Australia, these three measures have been implemented 
in inpatient, residential and ambulatory settings within 
public sector mental health services12 and the HoNOS 
is used in private hospitals with psychiatric beds.13 In 
New Zealand, the HoNOS, HoNOSCA, HoNOS 65+, 
HoNOS-LD and HoNOS-secure have been mandated for 
routine collection in mental health services.14 Elsewhere, 
the routine implementation of HoNOS measures has 
occurred in local contexts, or is under active consider-
ation. For example in Canada, the HoNOS, HoNOSCA 
and HoNOS 65+ are used in at least two provinces.15 
In the Netherlands HoNOS, HoNOSCA and HoNOS 
65+ have been used by various mental health services and 
are among instruments recommended by benchmarking 
systems for routine use.16 In Germany, HoNOS has been 
used in the sector of rehabilitative mental healthcare.17 
In Norway, the national Norwegian Patient Register is 
preparing for use of HoNOS and HoNOSCA as possible 
routine outcome measures,18 and the HoNOSCA is used 
routinely within several child and adolescent mental 
health services in Denmark, Sweden and Norway. Various 
HoNOS measures have been translated into languages 
including Norwegian, Danish, Dutch, Spanish, Italian, 
Greek, German, Lithuanian, French and Thai. The 
HoNOS measures were designed as clinician-rated 
measures, although self- and proxy-completed versions of 
the HoNOS, HoNOSCA and HoNOS 65+ have also been 
developed.19–21
Implementing routine outcomes monitoring in mental 
health services involves a substantial commitment of 
resources in training and education, data management, 
and analysis and reporting.12 It is therefore important 
that the measurement properties (ie, their reliability, 
validity and responsiveness or sensitivity to change) and 
practical aspects (ie, their interpretability and feasibility/
utility in practice) of selected measures are acceptable.22 23 
Consumers, carers, clinicians, managers, policy-makers 
and researchers require up-to-date, synthesised evidence 
about the performance of the HoNOS measures to help 
them decide whether these measures are fit for use with 
the intended service settings and populations. Systematic 
reviews can inform such decision-making, as they provide 
an opportunity to compare findings from individual 
studies on a ‘level playing field’ and consider the reasons 
for agreements and disagreements. They may provide an 
opportunity to establish benchmarks for measurement 
property metrics, against which clinicians can compare 
the measures’ performance in their own environment. 
Researchers also require this information to support 
their choice of measures when reporting or designing 
new studies.24
A preparatory scoping search located a number of 
reviews25–32 that have sought to systematically identify and 
evaluate available information on the measurement prop-
erties of one or more members of the HoNOS family of 
measures. These reviews report that, for the most part, the 
HoNOS measures demonstrate acceptable performance 
on various measurement properties, and a number have 
identified HoNOS measures as suitable candidates for 
routine outcomes monitoring for certain populations 
and purposes when evaluated against a set of predeter-
mined criteria.25–27 33 These reviews have also been useful 
in highlighting areas for potential improvement. For 
example, reviews have shown that the four HoNOS scales 
measuring aspects of social functioning (relationships, 
activities of daily living, living conditions, and occupation 
and activities) tend to perform less well than the other 
individual scales and other subscales and the total score.25 
Reviews have highlighted areas of conflicting evidence—
for example, with respect to the factor structure of the 
HoNOS,28 HoNOSCA28 and HoNOS 65+31 and aspects 
of their feasibility or utility.28 31 34 Reviews have also high-
lighted the absence of data, at particular points in time, 
for certain measurement properties—for example, the 
content validity of the HoNOSCA,28 test–retest reliability 
and construct validity of the HoNOS 65+,28 31 the test–
retest reliability of the HoNOS-secure26 29 and the internal 
consistency, test–retest reliability, and criterion validity of 
the HoNOS-LD.32
There is now more than 20 years of accumulated 
knowledge about the performance of the HoNOS and 
its variants, but there is no single, up-to-date evalua-
tion of a comprehensive range of measurement prop-
erties for all HoNOS measures. Given the widespread 
implementation and policy importance of the HoNOS 
measures, and their ongoing development, this would 
be an important reference point for all stakeholders. 
The most comprehensive review of the HoNOS, 
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HoNOSCA and HoNOS 65+ was conducted by Pirkis 
and colleagues28 who examined evidence regarding 
their reliability, validity, responsiveness, interpret-
ability and feasibility/utility from studies published 
up to 2005, regardless of treatment setting or popu-
lation. A later review supplemented these results with 
studies published up to 2011, and expanded coverage 
to include the HoNOS-LD and HoNOS-secure, but did 
not consider evidence of interpretability and feasibility/
utility for any measure.32 Other subsequent reviews 
have been undertaken pertaining to the HoNOS25 27 30 33 
and the HoNOSCA,27 but have been more narrow in 
scope, focused on: studies from a single population 
subgroup27 31 33; a subset of HoNOS scales25; or on one or 
two measurement properties only.27 30 33 The HoNOS-se-
cure has been the subject of two additional reviews, one 
considering literature up to 201129 and the other up to 
2015.26 However, being a relatively new measure, the 
number of available studies was small.
The existing reviews of the measurement properties 
of the HoNOS family of measures are, collectively, also 
limited in a number of methodological aspects. First, 
existing reviews have often excluded studies published 
in languages other than English or been unclear about 
whether they have been excluded. Given the number of 
languages that HoNOS measures have been translated 
into, excluding papers published in languages other 
than English may significantly under-represent the body 
of available evidence. Second, none of the previous 
reviews have applied detailed structured checklists35 36 
that standardise the appraisal of the quality of evidence 
on measurement properties. The benefits of structured 
checklists are that they provide guidance regarding 
which measurement properties are important and how 
to investigate them, and increase the likelihood that 
extracted results will be comparable across raters and 
studies.36 Third, all of the previous reviews have been 
descriptive; none have sought to apply meta-analytic tech-
niques to pool information across studies on measure-
ment property metrics. This has been done with other 
measures.24 37–39 Doing so may improve confidence in 
the reliability of findings, if they are replicated across 
multiple studies, and may increase the external validity 
of findings, if findings are maintained when samples of 
varying composition are pooled.40 41 Fourth, the existing 
reviews have not formally examined whether measure-
ment properties differ between subgroups defined by 
patient or study characteristics; factors such as patient 
mix and rater profession/experience or training may be 
important sources of variation.
The current systematic review will be undertaken to 
address the aforementioned gaps. Its objectives are to:
a. determine the extent of available evidence regard-
ing the measurement properties of clinician-rated 
measures in the HoNOS family, in relation to their 
reliability, validity, responsiveness (or sensitivity to 
change), interpretability and feasibility/utility (or 
acceptability);
b. examine the measurement properties of scales, sub-
scales and totals for each measure in the HoNOS 
family, and whether performance varies across sub-
groups (eg, defined by treatment setting, clinical 
grouping, age group and rater profession/experi-
ence or training);
c. apply meta-analytic techniques to generate pooled 
estimates of relevant measurement property metrics 
(eg, intraclass correlation coefficient (ICC), kappa, 
Cronbach’s alpha and Pearson’s correlation coeffi-
cient) for each clinician-rated HoNOS measure’s 




The review protocol was lodged with the PROSPERO 
(International Prospective Register of Systematic 
Reviews) on 22 February 2017 (CRD42017057871) and 
updated on 23 November 2017. It was developed in accor-
dance with the Preferred Reporting Items for System-
atic Reviews and Meta-Analysis Protocols (PRISMA-P) 
statement42 (see online supplementary appendix 2). 
The completed review will be reported according to the 
PRISMA guidelines.43 Protocol amendments will be docu-
mented on PROSPERO with the date of all amendments, 
and a description of the changes and the rationale.
search strategy
We will identify relevant peer-reviewed journal articles 
via a search of seven electronic databases from their 
inception: MEDLINE via EBSCOhost, PsycINFO via 
APA PsycNET, Embase via Elsevier, Cumulative Index to 
Nursing and Allied Health Literature via EBSCOhost, 
Web of Science via Thomson Reuters, Google Scholar 
and the Cochrane Library. Variants of the following 
terms will be searched as text words or keywords (as 
appropriate): ‘Health of the Nation Outcome Scales’ or 
‘HoNOS’ (see online supplementary appendix 3 for the 
full search strategy). Searches were initially undertaken in 
January 2017 and were updated in February 2018. Explor-
atory searches of non-English language databases (China 
Academic Journals of China National Knowledge Infra-
structure, Scientific Electronic Library Online via Web of 
Science, Russian Citation Index via Web of Science and 
Korean Citation Index—Korean Journal Database via 
Web of Science) were also undertaken, but these did not 
improve capture of eligible studies so were not incorpo-
rated into the search strategy. Reference lists of relevant 
articles will be scanned for additional studies. We will also 
contact the Royal College of Psychiatrists’ Research Unit 
in the UK for details of any additional publications they 
may be aware of.
The search will focus on identifying original published 
studies in the form of articles published in peer-re-
viewed journals. It is possible that some relevant studies 
may be published in doctoral theses and government or 
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other reports; however, these sources are more difficult 
to search for comprehensively. Exploratory searches for 
thesis and report material yielded only a small amount 
of material that was not also published in peer-reviewed 
journal articles, hence we excluded these sources from 
the search strategy. Database search results, including 
abstracts and full-text articles, as relevant, will be down-
loaded into the EndNote reference management soft-
ware package (EndNote V.X5.0.1).
selection of studies
Eligibility criteria
A study will be included if all the following six criteria 
are fulfilled: (1) it is published in full in a peer-reviewed 
journal (ie, abstracts, letters and other short communica-
tions will be excluded unless they provide sufficient infor-
mation to make the majority of required ratings); (2) its 
primary aim is to assess relevant measurement properties 
(within the domains of reliability, validity and responsive-
ness, as well as interpretability or feasibility/utility) for 
any of the HoNOS family of measures including: HoNOS, 
HoNOSCA, HoNOS 65+, HoNOS-secure, HoNOS-LD, 
HoNOS-ABI, HoNOS PbR or another HoNOS measure 
whose development has been described in the literature; 
(3) the HoNOS measure is clinician rated, regardless 
of mode of completion (eg, paper-and-pencil, directly 
entered into electronic medical record); (4) the clin-
ical characteristics of participants are consistent with the 
HoNOS measures’ target population; (5) relevant results 
are not duplicated elsewhere (where the same data are 
reported in more than one source, the more comprehen-
sive version will be included) and (6) a full text version 
can be obtained. We will restrict studies to those with 
the primary aim of developing or testing the measure-
ment properties of a HoNOS measure, as evidence from 
studies designed for other purposes may be difficult to 
interpret.44 There will be no restrictions placed on study 
design, setting, context of study or language of publi-
cation. Studies using any language versions of HoNOS 
measures will be included.
Screening process
Two reviewers will independently screen the titles and 
abstracts yielded by the search against the eligibility 
criteria. Full-text articles will be obtained when one of 
the two reviewers concludes that the abstract/titles indi-
cate that the HoNOS was potentially used in the study or 
when abstracts are not available. Relevant excerpts from 
articles published in languages other than English will be 
translated into English. Two reviewers will independently 
read the full-text articles and decide whether they meet 
the eligibility criteria. Disagreements will be resolved via 
discussion or, where consensus cannot be reached, with 
recourse to a third review author.
Appraisal of the methodological quality of included studies
The primary outcomes of this review will be the measure-
ment properties of the HoNOS measures. The scope 
of measurement properties considered in this review is 
based on the COnsensus-based Standards for the selec-
tion of health Measurement INstruments (COSMIN) 
taxonomy.36 In this taxonomy, measurement properties 
are clustered into domains—reliability (internal consis-
tency, test–retest reliability, inter-rater reliability and 
measurement error), validity (content validity, construct 
validity and criterion validity) and responsiveness. We 
will include interpretability, which is not considered as a 
measurement property in COSMIN, but is an important 
characteristic of a measurement instrument. We will 
also include feasibility/utility which is important when 
assessing items for use in routine service delivery contexts. 
The definitions for each domain, measurement property 
and specific aspects to be assessed are shown in table 1.
The appraisal of the methodological quality of the eval-
uation of measurement properties in included studies 
will be undertaken using the COSMIN checklist.36 45 46 
The checklist includes 12 boxes; each box corresponds to 
a measurement property or aspect and contains between 
4 and 18 items; each item is scored on a four-point rating 
scale (excellent, good, fair, poor) guided by descriptive 
anchor points.47 The items focus on study attributes 
specific to the evaluation of measurement properties, 
including items that assess the adequacy of sample sizes, 
and whether appropriate statistical tests were performed. 
An overall quality score for a given measurement prop-
erty is determined by taking the lowest rating assigned 
to any constituent item. For measurement proper-
ties where there is a particular item that is consistently 
under-reported, we may consider reporting the overall 
quality ratings with and without the inclusion of the item, 
informed by existing precedents (eg, Sitnikova et al48). 
A quality score will not be derived for feasibility/utility 
because it is not included in COSMIN. For studies that 
used item response theory (IRT) methods, an additional 
set of items is provided for recording whether the require-
ments for IRT models have been met. These ratings are 
then taken into account when assigning an overall rating 
score on each measurement property assessed in that 
study.
Complementary information about the quality of 
reporting of reliability studies will be evaluated using 
the Guidelines for Reporting Reliability and Agreement 
Studies (GRRAS)49 GRRAS comprises 15 guidelines that 
should be followed when agreement and reliability are 
reported. These cover the reporting of title and abstract 
(one guideline), introduction (four guidelines), methods 
(five guidelines), results (three guidelines), discussion 
(one guideline) and auxiliary material (one guideline). 
GRRAS guidance is narrative only; the guidelines are not 
accompanied by standardised system for coding the infor-
mation extracted from included studies.
data extraction
Data will be extracted from each study into a series of 
prespecified templates. For each study, we will capture 
information about:
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Table 1 Definitions of domains, measurement properties and aspects of measurement properties
Domain
Measurement property (and 
aspect) Definition
Reliability ‘The degree to which the measurement is free from measurement 
error.’36
Internal consistency ‘The degree of the interrelatedness among the items.’36
Test–retest reliability ‘The proportion of the total variance [in repeated measurements 
of patients who have not changed] which is because of true 
differences among patients.’36
Inter-rater reliability ‘The proportion of total variance [in repeated measurements by 
different persons on the same occasion] which is because of true 
differences among patients.’36
Measurement error ‘The systematic and random error of a patient’s score that is not 
attributed to true changes in the construct to be measured.’36
Validity ‘The degree to which [the] instrument measures the construct(s) it 
purports to measure.’36
Content validity ‘The degree to which the content of [the instrument’s scales 
and subscales] is an adequate reflection of the construct to be 
measured.’36
  Face validity ‘The degree to which (the items of) [the] instrument indeed looks 
as though they are an adequate reflection of the construct to be 
measured.’36
Construct validity ‘The degree to which the scores of [the] instrument are consistent 
with hypotheses (for instance with regard to internal relationships, 
relationships to scores of other measures or differences between 
relevant groups) based on the assumption that the instrument 
validly measures the constructs to be measured.’36
  Structural validity ‘The degree to which the scores of (the) instrument are an adequate 
reflection of the dimensionality of the construct to be measured’36
  Hypothesis testing (includes 
convergent, discriminant and 
known groups validity)
As per construct validity.36
  Cross-cultural validity ‘The degree to which the performance of the items on a translated 
or culturally adapted […] instrument are an adequate reflection 
of the performance of the items of the original version of the […] 
instrument.’36
Criterion validity (concurrent, 
predictive or postdictive)
‘The degree to which the scores on [the] instrument are an 
adequate reflection of a “gold standard”.’36
Responsiveness ‘The ability of [the] instrument to detect change over time in the 
construct to be measured.’36
Interpretability* ‘The degree to which one can assign qualitative meaning—that 
is, clinical or commonly understood connotations—to [the] 
instrument’s quantitative scores or change in scores.’36
Percentage of missing items
Description of how missing items 
were handled
Floor and ceiling effects ‘Percentage of respondents with the lowest possible score (floor 
effects) and highest possible score (ceiling effects).’24
Average scores ‘Reported baseline values for [the instrument’s scales and [or] 
subscales].’24
Minimally important change ‘Smallest change in a score that is considered to be important.’24
Feasibility/utility* ‘Degree to which the instrument is acceptable to and useful for 
stakeholders.’28
Time to complete ‘Reported time taken to complete [the instrument].’24
Continued
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 ► publication information (including authors, year);
 ► questionnaire characteristics (including the HoNOS 
measure(s) under evaluation; version number if rele-
vant; items used in the study or modifications made to 
the measure);
 ► study characteristics (year(s) of study entry; country; 
language of measure(s); study design; setting; eligi-
bility criteria; assessment occasion(s); sampling 
method; treatment/intervention type; experimental 
or routine conditions; and mode of HoNOS measure 
completion).
Some studies report multiple findings for a given meas-
urement property, based on different subgroups (defined 
by patient characteristics, setting, assessment occasion,or 
other study characteristics) or using more than one 
metric. Therefore for each subgroup, we will capture 
information about:
 ► subgroup characteristics (including clinical profile; 
mean age and SD or age range; percentage female; 
treatment setting; point in care; and rater profession/
experience and training in rating HoNOS);
 ► details of analysis (including number of patients 
involved; whether results pertain to scale, subscale or 
total score; metric reported and analyses undertaken);
 ► results reported (values on an appropriate metric or a 
narrative statement of results, as appropriate).
The COSMIN checklist with four-point rating scale 
will be completed for each study. For studies reporting 
on reliability, additional templates will be developed 
to capture the information required to assess the study 
against the GRRAS. For example, to assess the quality of 
reporting against GRRAS guideline 13 ‘report estimates 
of reliability and agreement including statistical measures 
of uncertainty’, information to be extracted will include: 
the reliability or agreement metric used; whether or not 
uncertainty was reported; whether a sample size calcula-
tion was performed; whether results were pooled across 
subgroups and, if so, the pooling procedure and evidence 
of heterogeneity.
Data extraction will be undertaken independently 
by two reviewers; discrepancies that cannot be resolved 
via discussion will be referred to a third review author. 
Where necessary, we will contact authors for clarification 
of published data. The data extraction templates will be 
piloted on several studies and modified as needed before 
use.
Methodological appraisal
Methodological appraisal of the measurement prop-
erties within the reliability, validity and responsiveness 
domains will be interpreted using the adequacy criteria 
proposed by the COSMIN group,50 modified as necessary 
drawing on precedents set by previous reviews24 51–53 For 
each measurement property examined in a given study, 
the reported findings will be compared with a statistical 
threshold for adequacy and rated on a three-point system 
indicating whether or not it meets the threshold (‘+’, posi-
tive rating; ‘?’, indeterminate rating; ‘−’, negative rating). 
By way of example, the original COSMIN adequacy 
criteria for inter-rater reliability are: ‘+’ ICC or weighted 
kappa ≥0.70; ‘?’ ICC or weighted kappa not reported; and 
‘-−’ ICC or weighted kappa <0.70. For interpretability and 
feasibility/utility, information regarding relevant aspects 
will be evaluated against available thresholds or, where 
thresholds are not available, via a narrative synthesis24 50
data synthesis
We will start by conducting a narrative synthesis of the 
information captured in the templates, comparing and 
contrasting methodological parameters and results 
across studies, and over time. Following COSMIN recom-
mendations,44 a best evidence synthesis will then be 
undertaken at the measurement property level. First, an 
overall rating (positive, indeterminate, negative) of the 
adequacy of each measurement property will be made. 
Second, a level of evidence (strong, moderate, limited, 
conflicting, unknown) of the methodological quality of 
the included studies for each measurement property will 
be assigned. The ratings will be guided by the original 
criteria developed by Terwee and colleagues47 and any 
relevant modifications.24 Qualitative findings regarding 
interpretability and feasibility/utility will be synthesised 
narratively. For reliability studies, quality of reporting 
information will be synthesised narratively, guided by the 
GRRAS.49
In undertaking these syntheses, we will initially consider 
information from different language versions of the same 
measure separately, as it cannot be assumed that different 
Domain
Measurement property (and 
aspect) Definition
Completion rate Percentage of clinicians completing the instrument in practice.28
Stakeholder perceptions May include views regarding: usefulness in treatment planning 
and clinical decision-making; usefulness in service evaluation 
and benchmarking; attitudes to routine outcome measurement; 
organisational/infrastructure barriers/enablers; training and 
feedback mechanisms; and protocols for assessment.22 27 28
*Interpretability and feasibility/utility are not considered measurement properties but are important characteristics of a measurement 
instrument.
Table 1 Continued 
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language versions will have the same measurement 
properties.53
In addition, where the volume of available data is 
adequate, meta-analyses will be undertaken using 
Comprehensive Meta-Analysis software V.3 to generate 
pooled estimates of relevant measurement property 
metrics (eg, ICC, kappa, Cronbach’s alpha and Pearson’s 
correlation coefficient) for individual scales, subscales 
and total scores. Syntheses will involve combining data 
at the level reported in the paper (eg, individual scale, 
subscale, 10-item total or 12-item total), not across levels. 
It is not our intention to synthesise data across variants of 
the HoNOS (eg, HoNOSCA and HoNOS-LD) or across 
versions of a given HoNOS measure (eg, if modifications 
have been made).
We will start by including all relevant values on the 
properties of interest in a meta-analysis and then inves-
tigate whether heterogeneity is lower for subgroups that 
would be expected to be more homogenous by design. We 
will test for statistical heterogeneity using the I2 statistic 
and, where present, will use the random effects model. If 
indicated, outcomes for subgroups of interest (eg, treat-
ment setting, rater profession/experience or training) 
will be explored using meta-regression or subgroup 
analysis. Where there are more than 10 studies for a 
particular outcome we will test for publication bias using 
funnel plots. To examine the impact of study quality, we 
will conduct sensitivity analyses by excluding studies of 
‘poor’ quality according to the COSMIN checklist. Where 
pooling of data across studies is not feasible, we will 
undertake narrative syntheses to explore differences in 
findings across subgroups, and according to study quality.
EthICs And dIssEMInAtIOn
No primary data will be collected, therefore ethics 
approval is not required. We intend to summarise the 
outcomes of this study in one or more reports and/
or presentations to the funder of this review. It is also 
planned that outcomes will be reported in peer-reviewed 
journal publications and in presentations at academic 
conferences and other meetings.
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